Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment

NCT05642806 is registered in ClinicalTrials.gov with St. Paul's Sinus Centre as lead sponsor.

NCT NCT05642806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05642806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment
Lead sponsor
St. Paul's Sinus Centre
Phase
Phase 4
Overall status
Unknown status
Start date
July 1, 2023
Completion date
June 30, 2025
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, chronic rhinosinusitis with nasal polyps, chronic rhinosinusitis without nasal polyps